Bain Capital Life Sciences Fund II, L.P. - Significant Ownership

Signature - Title
/s/ Andrew Hack - Andrew Hack, Partner of Bain Capital Life Sciences Investors, LLC
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Bain Capital Life Sciences Fund II, L.P..

Significant Ownership of Bain Capital Life Sciences Fund II, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SVRA Savara Inc. Common Stock, par value $0.001 per share 9.99% $51.4M 17.6M Bain Capital Life Sciences Fund II, L.P. Mar 25, 2025
CCCC C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.25% $13.5M 6.06M BCLS II Equity Opportunities, LP Oct 17, 2025
MRSN Mersana Therapeutics, Inc. Common Stock, par value $0.0001 per share 4% $1.52M 199K BCLS II Investco, LP Nov 12, 2025

Schedules 13D/G Reported by Bain Capital Life Sciences Fund II, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.